LEADER 04429nam 22007215 450 001 9910300077103321 005 20200701142134.0 010 $a1-4899-8050-4 024 7 $a10.1007/978-1-4899-8050-2 035 $a(CKB)2560000000148659 035 $a(EBL)1730873 035 $a(OCoLC)884584081 035 $a(SSID)ssj0001204984 035 $a(PQKBManifestationID)11658772 035 $a(PQKBTitleCode)TC0001204984 035 $a(PQKBWorkID)11191758 035 $a(PQKB)11285174 035 $a(MiAaPQ)EBC1730873 035 $a(DE-He213)978-1-4899-8050-2 035 $a(PPN)178316628 035 $a(EXLCZ)992560000000148659 100 $a20140421d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aMolecular Testing in Cancer /$fedited by George M. Yousef, Serge Jothy 205 $a1st ed. 2014. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2014. 215 $a1 online resource (437 p.) 300 $aDescription based upon print version of record. 311 $a1-322-03757-4 311 $a1-4899-8049-0 320 $aIncludes bibliographical references and index. 327 $aTransitioning Diagnostic Molecular Pathology to the Genomic Era: Cancer Somatic Mutation Panel Testing --  Conventional and Molecular Cytogenetics in Cancer --  Comparative Genomic Hybridization and Array based CGH in Cancer --  Polymerase Chain Reaction -- Single Nucleotide Polymorphisms (SNPs) --  Clinical Application of DNA Sequencing: Sanger and Next-Generation Platforms -- Microarray-based Investigations in Cancer -- Proteomics in Cancer Diagnostics -- Circulating Tumor Cells: A Non-Invasive Liquid Biopsy in Cancer -- Molecular Testing in Hematological Malignancies -- Molecular Testing in Breast Cancer --  Molecular Pathology of Gastrointestinal Tumors -- Molecular Testing in Pulmonary Tumors -- Molecular testing in Gynecological Malignancies -- Molecular Testing in Central Nervous System tumors -- Molecular Testing in Adult Kidney Tumors --  Molecular Testing in Prostate Cancer -- Molecular Testing in Urothelial Tumors -- Molecular Testing in Thyroid Cancer -- Molecular Testing of Head and Neck Tumors --  Molecular Testing in Bone and Soft Tissue Tumors -- Molecular testing in Cutaneous Melanoma -- Molecular Testing in Pediatric Tumors -- Pharmacogenomics in Molecular Oncology -- Quality Assurance in Molecular Testing of Cancer. 330 $aMolecular Testing in Cancer provides a state of the art review of clinically relevant molecular pathology in cancer. The book provides a brief, easy to read review of commonly employed diagnostic molecular techniques including recently developed "next generation" analytic tools, and offers a system-based run-through of the utility of molecular testing in individual cancer types, as well as reviewing current markers in cancer diagnosis, prognosis, and management. The volume also provides a prospective for the future which includes recently characterized and emerging biomarkers. Written by experts in the field, Molecular Testing in Cancer serves as a useful and comprehensive resource for pathologists, hematologists, laboratory technicians and molecular scientists. 606 $aPathology 606 $aHematology 606 $aLaboratory medicine 606 $aCancer research 606 $aPathology$3https://scigraph.springernature.com/ontologies/product-market-codes/H4800X 606 $aHematology$3https://scigraph.springernature.com/ontologies/product-market-codes/H3307X 606 $aLaboratory Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B15007 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 615 0$aPathology. 615 0$aHematology. 615 0$aLaboratory medicine. 615 0$aCancer research. 615 14$aPathology. 615 24$aHematology. 615 24$aLaboratory Medicine. 615 24$aCancer Research. 676 $a610 676 $a610724 676 $a614.5999 676 $a616.07 702 $aYousef$b George M$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aJothy$b Serge$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300077103321 996 $aMolecular Testing in Cancer$91522159 997 $aUNINA